PayChest Corporate Update HONG KONG--(Marketwired - Jun

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
PayChest Corporate Update

HONG KONG--(Marketwired - Jun 27, 2013) - PayChest, Inc. ( PINKSHEETS : PYCT ) ("the Company") wishes to announce an update to shareholders regarding corporate developments.

In April 2012, the Company became aware that the Depository Trust Company (DTC), a company that oversees and clears deposits of physical stock certificates in the US, imposed a temporary chill on accepting the Company's share certificates for deposit. These "chills" are designed to protect shareholders' interests and can be placed on Company certificate deposits for a variety of reasons. As far as the Company can tell, the temporary chill was triggered as a result of an increase in issued and outstanding shares, caused by preferred shareholders converting existing preferred stock into common stock.

Previously, under a number of agreements, certain of the Company's investors funded the Company by purchasing preferred stock with a conversion feature. These preferred stockholders converted their preferred stock into common stock to benefit from the possible upside of their investment. As such, the group converted 545,000 shares of preferred stock at $0.0001 resulting in the issuance of 5,450,000,000 shares of common stock. Many of those shares cannot be deposited into the DTC clearing system for possible future sale.

The DTC chill can, and does, affect a company's funding source in that it influences the internal policies and procedures of some brokerage firms. One such policy is that some brokers have restricted or blocked buy orders from customers wishing to purchase the Company's shares on the open market. As a result, trading volumes are at historic lows. Funding has been limited to a maintenance basis whereby only essential capital requirements will be funded. According to the funding sources, upon removal of the chill, further ongoing funding is slated to return.

Previously, the Company announced a $1.2 million purchase order for 16 containers of Mibella flushable and biodegradable sanitary products with a UK distributor. Each container wholesales for approximately $75,000, depending on product and pack size mix. In a typical sales cycle, our Company would pay for some or all of the production materials in advance. The contractual risk of starting supply and then stopping threatened the distributor and end customer with an unreliable supply chain that would have damaged confidence. The Company anticipates the purchase order will be fulfilled after the chill is lifted and finance is flowing again.

For legal reasons, news releases have been infrequent while the Company has been addressing the DTC chill until a plan was agreed upon. The Company and our legal counsel have been working with the DTC to provide them with the necessary documentation the DTC has requested. The Company has addressed a number of specific issues raised by the DTC. The Company now needs to address one final issue and propose a plan of action to the DTC to bring this to a conclusion. The Company must execute this action plan in a timely manner and is confident that once the plan has been executed and all necessary documents delivered to the DTC, they will remove the chill.

Through this time, the Company has continued to produce and release its quarterly and annual filings. The Company's filings are submitted with the OTC markets and can be found on www.otcmarkets.com .

Shareholders and interested parties are encouraged to call or e-mail the Company and be put on the Company's e-mail list for upcoming news releases.

NOTES ABOUT FORWARD-LOOKING STATEMENTS Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company's filings with OTC Markets http://www.otcmarkets.com/stock/PYCT/financials

Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made.

Historical news releases on the Company can be found at http://www.paychest.com/news.htm

Contact: PayChest, Inc. ir@paychest.com Tom Hands 1-416-619-5242 from overseas: +1-416-619-5242 Tobie Oliver 1-800-624-7479 from overseas: +1-714-274-7206

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leqembi Pen Revolutionizes Alzheimer's Care in Japan

Updated Category News Views 22

Innovative Alzheimer's Treatment Hits Japanese Market Just when you think the medical world needs a jolt of innovation, BioArctic rolls out something that could change how Alzheimer's is managed. With their subcutaneous Leqembi Pen, they've just added another feather in their cap, launching in Japan after a successful U.S. introduction. Not just your run-of-the-mill...

Continue Reading
Randi Baptiste Sets a New Standard in Youth Sports

Updated Category News Views 62

Youth Sports: Revolutionized by Randi Baptiste In an era where youth sports face a minefield of health risks and performance pressures, Randi Baptiste stands out. This isn't just about running around the park—this is about fundamentally transforming how we think about athletic development for young folks. Recognizing Baptiste for his contributions, The Inner Circle...

Continue Reading
Simform's AI Innovations Earns Microsoft Award Nod

Updated Category News Views 64

Riding the AI Wave with Simform In the chaotic world of AI and tech partnerships, earning recognition from a powerhouse like Microsoft ain't your run-of-the-mill achievement. Simform being recognized as a finalist for the 2026 Microsoft Innovate with Azure AI Apps and Agents Partner of the Year Award is a big deal, not just for them, but as a beacon of inspiration for...

Continue Reading
GAC's Green Push Unveils 3rd Showroom in Casablanca

Updated Category News Views 146

Pushing Through North Africa's Automotive Shift Well, looks like GAC is showing they're not just dabbling in North Africa—they're planting some sturdy roots in that rocky soil. Opening their third showroom in Casablanca, GAC isn't just settling for sidelines. They're step-in-the-ring serious about carving their name on North African roads. This isn't some skin-deep...

Continue Reading
Adam Foundation's Ramadan Effort to Cut Plastic Waste

Updated Category News Views 27

Environmental Consciousness: A Call from Antalya Here we go again, folks. Something refreshing is brewing over in Antalya at COP31, where the UK-based Adam Foundation has made a move that resonates beyond the usual hubbub. No smoke and mirrors, just straightforward action aimed at cutting down the wave of plastic waste during Ramadan. This isn't some pie-in-the-sky green...

Continue Reading
FF EAI Robotics Aims for Top Spot in K-12 Tech

Updated Category News Views 28

FFR's Shot at Robotics Education Dominance You ever feel like a company is throwing everything but the kitchen sink at an opportunity? That's FF EAI Robotics for you—charging ahead with a hefty laundry list of tech ambitions. They've clocked in about $2.3 million in revenue from their newly acquired robotics wing for the first nine months of 2026, showing a 26% gross...

Continue Reading
Rethinking Risk: AI, Cyber, and Ops Convergence

Updated Category News Views 28

Risk Management's New Frontier Hold onto your hats, folks, because the landscape of risk management is shifting under our feet—and not a minute too soon. With AI adoption skyrocketing, cybersecurity threats piling up like never-ending junk mail, and operational hurdles lurking around every corner, Wipfli's throwing down the gauntlet for business leaders to wise up....

Continue Reading
Implantica's Q3 2026: A Potential Leap Forward?

Updated Category News Views 34

Implantica Prepares to Unveil Q3 Results We're heading into the home stretch for 2026, and Implantica's about to unveil its third-quarter results. With its presentation scheduled for November 19 at 15:00 CET, this medtech outfit has caught some eyes, especially with their flagship offering, RefluxStop®. Paying attention here might be worthwhile, as this plays into a...

Continue Reading
Squeez and Qentelli Join Forces to Revolutionize Loyalty

Updated Category News Views 438

A New Era of Loyalty Commerce The winds are changing in the loyalty game, and it's about time someone shook things up. Squeez has teamed up with Qentelli, thanks to a $1 million investment, to kick-start this next wave of commerce. And boy, it's not just about money—it's like combining brains with brawn. Squeez isn't just offering loyalty programs anymore; they're...

Continue Reading
Vipshop Sets 2026 AGM: Shareholders Meet on Dec 8

Updated Category News Views 21

Blockbuster or Bust: Vipshop's Upcoming AGM Here's the scoop: Vipshop Holdings Limited, with its mammoth operations in China's off-price retail sector, is gearing up for its annual general meeting (AGM) on December 8, 2026. This is where management and stakeholders will hash out everything from strategic pivots to financial health. Forget shareholder votes this...

Continue Reading

Top 5 Most Recently Viewed Articles

Actinium Pharmaceuticals Faces Class Action Lawsuit for Losses

Updated Category News Views 198

Actinium Pharmaceuticals: A Closer Look at the Lawsuit Recently, a significant class action lawsuit was filed against Actinium Pharmaceuticals, Inc. (NYSE: ATNM). This legal action is vital for investors who have experienced financial losses associated with their investments in Actinium's stock. The lawsuit, initiated by Pomerantz LLP, accuses the company and some of its...

Continue Reading
Uranium Energy Corp Delivers Promising Drill Results at Roughrider

Updated Category News Views 69

Uranium Energy Corp Unveils Outstanding Drilling Results Uranium Energy Corp (NYSE American: UEC) is thrilled to share the latest findings from its active drilling campaign at the Roughrider Project, which have revealed striking high-grade uranium mineralization. A drill hole positioned 850 meters northeast of the central Roughrider deposit has showcased remarkable...

Continue Reading
TME Pharma Presents Promising Glioblastoma Trial Outcomes

Updated Category News Views 159

TME Pharma's Progress in Glioblastoma Treatment TME Pharma N.V. is a clinical-stage biotechnology company dedicated to developing innovative therapies for cancer. Recently, they announced an important oral presentation at a renowned medical congress, showcasing the encouraging results from the NOX-A12 GLORIA Phase 1/2 trial. This study aims to address glioblastoma, a...

Continue Reading
Life Time Champions Expanding Pickleball Facilities Across U.S.

Updated Category News Views 327

Life Time Champions Expanding Pickleball Facilities Across U.S. Life Time (NYSE: LTH) proudly marks World Pickleball Day as the sport continues to gain unprecedented popularity across America. With over 750 permanent pickleball courts established within its athletic country clubs, the organization demonstrates its commitment to being at the forefront of this dynamic...

Continue Reading
Edgewise Therapeutics Shares Breakthrough EDG-7500 Results

Updated Category News Views 305

Edgewise Therapeutics Announces Significant Progress in Hypertrophic Cardiomyopathy Treatment Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a pioneering biopharmaceutical company focused on muscle diseases, has recently disclosed positive outcomes from their Phase 2 CIRRUS-HCM trial studying EDG-7500. This treatment targets hypertrophic cardiomyopathy (HCM), a serious...

Continue Reading